Mobile Phone-Based Web-Page: HPV vaccine for Human Papillomavirus

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Human Papillomavirus+4 MoreMobile Phone-Based Web-Page: HPV vaccine - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a tailored, health communication intervention can increase HPV vaccination rates among underserved, vaccine hesitant parents.

Eligible Conditions
  • Human Papillomavirus
  • Vaccine Refusal
  • Parenting
  • Human Papillomavirus-Related Carcinoma
  • Autism Spectrum Disorder

Treatment Effectiveness

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: 6 months

6 months
Data collection processes
HPV vaccine rates
Recruitment Rates
Retention Rates

Trial Safety

Trial Design

2 Treatment Groups

Mobile Phone-Based Web-Page: Healthy Lifestyles
1 of 2
Mobile Phone-Based Web-Page: HPV vaccine
1 of 2

Active Control

Experimental Treatment

244 Total Participants · 2 Treatment Groups

Primary Treatment: Mobile Phone-Based Web-Page: HPV vaccine · No Placebo Group · N/A

Mobile Phone-Based Web-Page: HPV vaccine
Behavioral
Experimental Group · 1 Intervention: Mobile Phone-Based Web-Page: HPV vaccine · Intervention Types: Behavioral
Mobile Phone-Based Web-Page: Healthy Lifestyles
Behavioral
ActiveComparator Group · 1 Intervention: Mobile Phone-Based Web-Page: HPV vaccine · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

Meharry Medical CollegeLead Sponsor
17 Previous Clinical Trials
5,490 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a smartphone.
You must be able to speak English.
You did not participate in Aim 1 Stage 1.
You have not participated in Aim 1 Stage 1 or Aim 1 Stage 2.